netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Pemetrexed found 9 matches
Open monograph to display formulary status BNF Category
  Cytotoxic Drug Pemetrexed Malignant disease and immunosuppression - Antimetabolites - 08.01.03
  Cytotoxic Drug Pembrolizumab  (Keytruda®) Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA1060: Osimertinib with pemetrexed and platinum-based chemotherapy for untreated EGFR mutation-positive advanced non-small-cell lung cancer (08.02.04)
link in drug section NICE TA124: Pemetrexed for the treatment of non-small-cell lung cancer (08.01.03)
link in drug section NICE TA135: Pemetrexed for the treatment of malignant pleural mesothelioma (08.01.03)
link in drug section NICE TA181: Pemetrexed for the first-line treatment of non-small-cell lung cancer (08.01.03)
link in drug section NICE TA190: Pemetrexed for the maintenance treatment of non-small-cell lung cancer (08.01.03)
link in drug section NICE TA402: Pemetrexed maintenance treatment for non-squamous non-small-cell lung cancer after pemetrexed and cisplatin (08.01.03)
link in drug section NICE TA683: Pembrolizumab with pemetrexed and platinum chemotherapy for untreated, metastatic, non-squamous non-small-cell lung cancer (08.01.05)


 
netFormulary